Contract · Federal · No Set aside used
Human Hindbrain Organoid Functional Assay Services.
- Agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION
- Location
- Rockville, MD
- Amount
- Amount not listed
- Posted
- Sep 11, 2026
- Set-aside
- No Set aside used
- NAICS code
- 541714 - Scientific Research and Development Services (general category) look up NAICS codes
- PSC code
- B504
Timeline
-
Posted
Sep 11, 2026
-
Status
Closing soon
What contracts like this typically pay
No award history yet for this category (NAICS 541714).
What this contract is for
- Agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION
- Location
- Rockville, MD
- Set-aside
- No Set aside used
- NAICS
- 541714 - Scientific Research and Development Services (general category)
- Scope
- Federal
The U.S.
Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Division of Applied Regulatory Science (DARS), intends to award a sole-source, Firm-Fixed-Price purchase order to OrganoTherapeutics SARL for Human iPSC-Derived Hindbrain Organoid Functional Assay Services.
The requirement includes the provision of human induced pluripotent stem cell (iPSC)-derived hindbrain organoids and associated materials necessary to support in vitro research evaluating drug-induced effects on respiratory-relevant neural circuits.
The contractor will also perform functional characterization of the organoids using three-dimensional multi-electrode array (3D MEA) technology to assess electrophysiological responses to drugs known to affect respiratory function.
The functional characterization includes testing FDA-identified drug and reversal-agent combinations, MEA measurements, evaluation of batch-to-batch reproducibility, collection of exposed drug solutions for FDA verification, data analysis, and delivery of raw data, analyzed data, analysis files, and study reports.
The requirement also includes twelve scheduled deliveries of human hindbrain organoids to the FDA White Oak Campus.
The first delivery will consist of 96 organoids, with subsequent deliveries consisting of 48 organoids each.
Functional characterization will be performed at the contractor's laboratory.
The anticipated period of performance is eighteen (18) months from the date of award.
This acquisition is being conducted as a commercial service acquisition under RFO FAR Part 12.
The Government's decision to restrict competition is documented pursuant to RFO FAR 12.102(a).
Market research identified OrganoTherapeutics SARL as the only source capable of satisfying the Government's complete requirement for...
Official solicitation and documents
The full solicitation, any attachments, and the actual submission instructions live on the official listing, not on this page. Oppward summarizes public record data; it does not host or mirror the source documents.
Oppward is an independent service and is not affiliated with, endorsed by, or sponsored by SAM.gov or any government agency. This page is a plain-English summary of public record data; the linked source above is the authoritative listing.
How to bid on this
This is a contract solicitation, not a grant. To bid, you submit a proposal (usually a price and a description of how you would do the work) directly to the government, through the channel the official listing specifies, not through Oppward.
- Make sure your business has an active SAM.gov registration. You cannot be paid on a federal contract without one.
- Read the full solicitation on the official listing above, especially the scope of work, not just this summary. Our guide to reading a solicitation walks through what to look for.
- Check the set-aside listed above and confirm your business actually qualifies for it before you spend time on a proposal. See our guide to set-asides if the category is unfamiliar.
- Submit your proposal by the deadline, using the exact submission method the official listing states. A technically on-time bid sent the wrong way is often treated as late.
Get contracts like this one matched to your business, free.